Press What’s news at AbelsonTaylor Group
Select category
Leveraging Multi-Touch Attribution for Greater Brand Marketing Success
Even in the present age of AI, big data and omnichannel marketing, pharma brands—for the most part—are stuck to the traditional idea that the last touch, the last communication someone receives before converting, should get all, or most of the credit for that conversion. Or, they might not even know which touchpoints to attribute credit.
In her article in Muse by Clio, Rebecca Visconti, VP of Marketing Intelligence, looks beyond that conventional worship of the last touch to provide evidence-based methods to calculate the real impact of every touchpoint more accurately.
Read the full article at Muse by Clio
Media Contact:
Recent Posts
From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionRob Chartier Joins AbelsonTaylor Group as Director of Engagement Strategy
AbelsonTaylor Group today announced that Rob Chartier has joined the agency as Director of Engagement Strategy. Chartier brings more than...
Read Press Read more Rob Chartier Joins AbelsonTaylor Group as Director of Engagement StrategyThe Human Story Underneath the Data: Translating Clinical Rigor into Brand Strategy
In an interivew with Roastbrief US, Planning Director Elise Pietracatella explains how at AbelsonTaylor Group believes the science and the...
In the News Read more The Human Story Underneath the Data: Translating Clinical Rigor into Brand StrategyConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.